Tilray Settles Shareholder Lawsuit With $39.9M, Approved By Delaware's Court Of Chancery
Recently, an investor sued Tilray Brands Inc. (NASDAQ: TLRY) by alleging the Canadian pharmaceutical and cannabis company and popular cannabis stock “breaches of fiduciary duties, unjust enrichment, and waste of corporate assets, an
